Restenosis following coronary angioplasty: Clinical presentations and therapeutic options
暂无分享,去创建一个
[1] R. Waugh,et al. Usefulness of dobutamine echocardiography for detecting restenosis after percutaneous transluminal coronary angioplasty. , 1993, The American journal of cardiology.
[2] P. Serruys,et al. Wiktor stent implantation in patients with restenosis following balloon angioplasty of a native coronary artery. , 1992, The American journal of cardiology.
[3] R. Califf,et al. Low Molecular Weight Heparin in Prevention of Restenosis After Angioplasty: Results of Enoxaparin Restenosis (ERA) Trial , 1994, Circulation.
[4] M. Nobuyoshi,et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. , 1988, Journal of the American College of Cardiology.
[5] R. Califf,et al. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. , 1994, The American journal of cardiology.
[6] P. Teirstein,et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.
[7] W. Weintraub,et al. Initial management and long-term clinical outcome of restenosis after initially successful percutaneous transluminal coronary angioplasty. , 1992, The American journal of cardiology.
[8] J. Joelson,et al. Angiographic findings when chest pain recurs after successful percutaneous transluminal coronary angioplasty. , 1987, The American journal of cardiology.
[9] L Schwartz,et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. , 1988, The New England journal of medicine.
[10] M. Savage,et al. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. M-HEART Group. , 1990, Circulation.
[11] R. Taylor,et al. Effects of low-dose aspirin on restenosis after coronary angioplasty. , 1991, The American journal of cardiology.
[12] W. Desmet,et al. Immediate and 6-month follow-up results of coronary angioplasty for restenosis: analysis of factors predicting recurrent clinical restenosis. , 1993, American heart journal.
[13] S Levine,et al. Coronary angioplasty: clinical and angiographic follow-up. , 1985, The American journal of cardiology.
[14] W. Rutishauser,et al. Restenosis and repeat coronary angioplasty in Geneva. , 1988, European heart journal.
[15] H. Höpp,et al. A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA. , 1993, Catheterization and cardiovascular diagnosis.
[16] J. Kisslo,et al. Exercise echocardiography is a valuable adjunct to treadmill testing for detection of restenosis after coronary angioplasty , 1990 .
[17] D. Waters,et al. Treatment of recurrent restenosis with repeat percutaneous transluminal coronary angioplasty. , 1988, The American journal of cardiology.
[18] V. Flintoft,et al. Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. , 1990, Journal of the American College of Cardiology.
[19] C. White,et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? , 1984, The New England journal of medicine.
[20] P. Armstrong,et al. Aggressive clinical pattern of angina at restenosis following coronary angioplasty in unstable angina. , 1992, American heart journal.
[21] F. Sacks,et al. RANDOMISED TRIAL OF FISH OIL FOR PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY , 1989, The Lancet.
[22] P. Camici,et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. , 1994, The New England journal of medicine.
[23] J. Douglas,et al. Repeat coronary angioplasty: correlates of a second restenosis. , 1988, Journal of the American College of Cardiology.
[24] S. Kelsey,et al. Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis. , 1984, The American journal of cardiology.
[25] U. Welsch,et al. Analysis of atherectomy specimens. , 1993, The American journal of cardiology.
[26] S. Schnitt,et al. Histologic findings in specimens obtained by percutaneous directional coronary atherectomy. , 1992, Human pathology.
[27] C. Buller,et al. Intracoronary ultrasound predictors of adverse outcomes after coronary artery interventions. , 1992, Journal of the American College of Cardiology.
[28] W M Breisblatt,et al. Stress thallium-201 imaging after coronary angioplasty predicts restenosis and recurrent symptoms. , 1988, Journal of the American College of Cardiology.
[29] P. Teirstein,et al. Repeat coronary angioplasty: efficacy of a third angioplasty for a second restenosis. , 1989, Journal of the American College of Cardiology.
[30] C. Simpfendorfer,et al. Repeat coronary angioplasty as treatment for restenosis. , 1992, Journal of the American College of Cardiology.
[31] M. Bourassa,et al. Restenosis after successful percutaneous transluminal coronary angioplasty: the Montreal Heart Institute experience. , 1987, The American journal of cardiology.
[32] R. Califf,et al. Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. , 1989, The American journal of cardiology.
[33] D. Baim,et al. Defining coronary restenosis. Newer clinical and angiographic paradigms. , 1993, Circulation.
[34] J. Douglas,et al. Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study. , 1984, Circulation.
[35] M. Bell,et al. Results of directional atherectomy of primary atheromatous and restenosis lesions in coronary arteries and saphenous vein grafts. , 1992, The American journal of cardiology.
[36] S. Epstein,et al. The basis of molecular strategies for treating coronary restenosis after angioplasty. , 1994, Journal of the American College of Cardiology.
[37] D. Baim,et al. Analysis of late lumen narrowing after excimer laser-facilitated coronary angioplasty. , 1994, Journal of the American College of Cardiology.
[38] D. Faxon,et al. Pharmacologic prevention of restenosis after coronary angioplasty: review of the randomized clinical trials. , 1993, Coronary artery disease.
[39] I. Bairati,et al. Double‐Blind, Randomized, Controlled Trial of Fish Oil Supplements in Prevention of Recurrence of Stenosis After Coronary Angioplasty , 1992, Circulation.
[40] Percutaneous transluminal coronary angioplasty more than twice for the same coronary lesion. , 1989, European heart journal.
[41] E. Topol,et al. Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group. , 1994, Circulation.
[42] M. Kaltenbach,et al. Recurrent restenosis after transluminal coronary angioplasty--dilatation or surgery? , 1988, European heart journal.
[43] P. Serruys,et al. Patient, lesion, and procedural variables as risk factors for luminal re- narrowing after successful coronary angioplasty: A quantitative analysis in 653 patients with 778 lesions , 1993 .
[44] J. O’Keefe,et al. Effects of diltiazem on complications and restenosis after coronary angioplasty. , 1991, The American journal of cardiology.
[45] M A Hlatky,et al. Detection of restenosis after elective percutaneous transluminal coronary angioplasty using the exercise treadmill test. , 1990, The American journal of cardiology.
[46] K. Kodama,et al. Restenosis after percutaneous transluminal coronary angioplasty--a histopathological study using autopsied hearts. , 1990, Japanese circulation journal.
[47] R. Califf,et al. Restenosis after coronary angioplasty: an overview. , 1991, Journal of the American College of Cardiology.
[48] A. Jacobs,et al. Outcome in patients with recurrent restenosis after percutaneous transluminal balloon angioplasty. , 1989, British heart journal.
[49] M. Nobuyoshi,et al. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. , 1991, Journal of the American College of Cardiology.
[50] E J Topol,et al. Caveats about elective coronary stenting. , 1994, The New England journal of medicine.
[51] Charles L. Brown,et al. Can restenosis after coronary angioplasty be predicted from clinical variables? , 1993, Journal of the American College of Cardiology.
[52] A. Íñiguez,et al. Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty. , 1992, Journal of the American College of Cardiology.
[53] Lippincott Williams Wilkins,et al. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angiopla , 1992, Circulation.
[54] W Rutsch,et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.
[55] D. Ricci,et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. , 1993, The New England journal of medicine.
[56] M. Leon,et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. , 1994, Science.
[57] R. Califf,et al. A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease , 1993 .
[58] C. White,et al. Percutaneous coronary angioscopy in patients with restenosis after coronary angioplasty. , 1991, Journal of the American College of Cardiology.
[59] G. Schuler,et al. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. , 1994, British heart journal.
[60] J. Douglas,et al. Restenosis after percutaneous transluminal coronary angioplasty: the Emory University Hospital experience. , 1987, The American journal of cardiology.
[61] M. Kern,et al. Repeat coronary angioplasty for restenosis: results and predictors of follow-up clinical events. , 1989, American heart journal.
[62] B. Marchandise,et al. Long-term outcome of patients with asymptomatic restenosis after percutaneous transluminal coronary angioplasty. , 1993, The American journal of cardiology.
[63] R E Vlietstra,et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.
[64] M. Leon,et al. Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3,000 patients. The ELCA Investigators. , 1994, Journal of the American College of Cardiology.
[65] T. Strecker,et al. Recognition of restenosis: can patients be defined in whom the exercise-ECG result makes angiographic restudy unnecessary? , 1989 .
[66] K. Gould,et al. Coronary flow reserve as a physiologic measure of stenosis severity. , 1990, Journal of the American College of Cardiology.
[67] C. Bauters,et al. Clinical characteristics and angiographic follow-up of patients undergoing early or late repeat dilation for a first restenosis. , 1992, Journal of the American College of Cardiology.
[68] B Meier,et al. Repeat coronary angioplasty. , 1984, Journal of the American College of Cardiology.
[69] R. Califf,et al. Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months , 1994, The Lancet.
[70] B. Meier,et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. , 1986, Journal of the American College of Cardiology.
[71] P W Serruys,et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. , 1988, Circulation.
[72] S. Ellis,et al. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. , 1989, American heart journal.